ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,921Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 434

$734K Total Retail Price of All Prescriptions

Rank: 15 out of 434

824 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 824 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 824 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 658 424 S3 1 4
LISINOPRIL 611 513 2 1
SIMVASTATIN 559 442 3 2
OMEPRAZOLE 504 417 4 5
LEVOTHYROXINE SODIUM 475 389 5 3
AMLODIPINE BESYLATE 322 291 6 6
METFORMIN HCL 293 251 7 7
METOPROLOL TARTRATE 256 210 8 12
FUROSEMIDE 236 200 9 9
ATENOLOL 235 202 10 16
OXYCODONE HCL 223 87 S2 11 34
LOVASTATIN 214 194 12 10
HYDROCHLOROTHIAZIDE 194 157 13 8
CARISOPRODOL 189 42 R 14 44
POTASSIUM CHLORIDE 173 161 15 20
ALENDRONATE SODIUM 165 153 16 15
GABAPENTIN 160 85 17 14
PRAVASTATIN SODIUM 155 127 18 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 142 19 21
ZOLPIDEM TARTRATE 153 105 20 11
WARFARIN SODIUM 150 101 21 18
LOSARTAN POTASSIUM 145 127 22 13
OXYCODONE HCL-ACETAMINOPHEN 132 96 S2 23 53
SERTRALINE HCL 129 82 24 27
ATORVASTATIN CALCIUM 129 109 24 19
CITALOPRAM HBR 122 115 26 23
IBUPROFEN 116 60 27 56
FLUTICASONE PROPIONATE 109 82 28 26
METOPROLOL SUCCINATE 109 100 28 22
CARVEDILOL 105 88 30 24
FLUOXETINE HCL 105 67 30 32
VENTOLIN HFA 101 57 32 30
CLOPIDOGREL 100 89 33 41
PLAVIX 95 93 34 64
TERAZOSIN HCL 95 91 34 40
MORPHINE SULFATE ER 92 22 S2 36 50
AZITHROMYCIN 91 71 37 38
ALLOPURINOL 89 89 38 25
TAMSULOSIN HCL 84 82 39 29
MORPHINE SULFATE 82 50 S2 40 194
GLIPIZIDE 82 71 40 37
GLIMEPIRIDE 78 56 42 58
PANTOPRAZOLE SODIUM 74 46 43 66
TRIAMTERENE-HCTZ 73 62 44 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 50 45 96
AMOXICILLIN 72 46 45 114
RANITIDINE HCL 70 61 47 31
TRAZODONE HCL 70 21 47 33
PREDNISONE 69 68 49 42
TRAMADOL HCL 68 62 50 28
CIPROFLOXACIN HCL 68 48 50 55
PROAIR HFA 67 39 52 60
HYDROMORPHONE HCL 66 25 S2 53 174
ESTRADIOL 66 47 R 53 73
FINASTERIDE 62 50 55 54
DIGOXIN 62 59 55 69
LOSARTAN-HYDROCHLOROTHIAZIDE 60 56 57 39
VENLAFAXINE HCL ER 59 17 58 184
SYNTHROID 54 37 59 67
HYDRALAZINE HCL 53 47 60 79
BENAZEPRIL HCL 53 52 60 49
CELEBREX 52 41 62 144
OXYBUTYNIN CHLORIDE 52 47 62 82
MELOXICAM 51 35 64 46
ADVAIR DISKUS 50 34 65 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.